You are not logged in. This means
you CAN ONLY VIEW reports that were published prior to Wednesday, September 18, 2024. You
MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.
MIDDAY BREAKOUTS REPORT - TUESDAY, AUGUST 27TH, 2024
Previous Mid Day Report Next Mid Day Report >>>
|
DOW 41182.18 -58.34 (-0.14%) | NASDAQ 17733.05 7.29 (0.04%) | S&P 500 5618.83 1.99 (0.04%)
|
Time of Screening :
8/27/2024 1:19:10 PM Report Released :
8/27/2024 1:50:44 PM Price is:
Above 52W High and Less Than 52W High
but within 15% of the 52 Week High Volume Is:
At least 75% of 50 Day Average at
the time of the screening.
More details about this report...
At around
mid-way through each trading day we run
a screen against our database of
high-ranked stocks, searching for
possible buy candidates that are trading
at or near their 52-week high on above
average volume. The results of that
screen are split into the two sections
you see below. The first, titled
"TODAY's FEATURED STOCKS" shows stocks
that our experts have recently
identified as among the strongest candidates to
consider. Stocks highlighted in yellow
are the most timely and noteworthy, so
particular attention and prompt action
may be appropriate. The second section,
titled "TODAY's BREAKOUT SCREEN" shows
the remainder of stocks meeting today's
screen parameters. Our experts have
reviewed and included notes on these
stocks as well, but found that they may
not match up as favorably.
|
Y - Today's strongest
candidates
highlighted
by our staff
of experts.
|
|
G - Previously featured in
this report as yellow and
now may no longer be buyable
under the guidelines.
|
|
|
NONE OF OUR FEATURED STOCKS MET TODAY'S SCREENING CRITERIA FOR VOLUME AND PRICE ACTION.
|
|
|
Symbol - Exchange - Industry Group Company Name |
Last |
Chg |
Day High |
52 WK Hi |
% From Hi |
Volume % DAV |
DAV |
CFB
- NASDAQ - Banks-Midwest
Crossfirst Bankshares
|
$17.87 |
-0.46 -2.51%
|
$18.49
|
$19.22
|
-7.02% |
562,009 168.77%
|
333,000
|
Most Recent Note for CFB - 8/27/2024 1:21:47 PM
Perched near its 52-week high but pulling back today for a volume-driven loss. Last noted with caution in the 7/18/24 - "Fundamentals are not a match with the fact-based investment system's guidelines (C and A criteria)."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
HEI
- NYSE - AEROSPACE/DEFENSE - Aerospace/Defense Products & Services
Heico Corp
|
$246.32 |
+0.42
0.17%
|
$247.23
|
$258.84
|
-4.84% |
445,234 118.10%
|
377,000
|
Most Recent Note for HEI - 8/27/2024 1:34:38 PM
Perched at its all-time high stubbornly holding its ground following noted volume-driven gains. Reported Jul '24 quarterly earnings +31% on +37% sales revenues versus the year-ago period. Prior quarterly comparisons versus the year-ago periods have not been strong and steady above the +25% minimum earnings guideline (C criteria) of the fact-based investment system.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
HMY
- NYSE - METALS & MINING - Gold
Harmony Gold Mng Co Adr
|
$10.21 |
-0.04 -0.34%
|
$10.49
|
$11.37
|
-10.25% |
3,414,268 82.71%
|
4,128,000
|
Most Recent Note for HMY - 8/27/2024 1:37:13 PM
Pulled back with higher volume after wedging to new multi-year highs. This South Africa based gold mining company was noted in prior mid-day reports - "Reported strong Sep and Dec '23 quarterly earnings results versus the year-ago periods. Annual earnings history (A criteria) has been erratic and included a downturn in FY '22, not a match with the fact-based investment system's fundamental guidelines."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
KEQU
- NASDAQ - ELECTRONICS - Scientific & Technical Instrum
Kewaunee Scientific Corp
|
$53.61 |
+0.31
0.58%
|
$54.29
|
$55.62
|
-3.61% |
23,821 79.40%
|
30,000
|
Most Recent Note for KEQU - 8/27/2024 1:39:09 PM
It has not formed a sound base of sufficient length yet found support when consolidating above its 50 DMA line ($47.64) in recent weeks. Noted with caution in prior mid-day reports - "Reported strong earnings increases in recent quarters through Apr '24. Subpar sales revenues growth and annual earnings (A criteria) history is not a match with the fact-based investment system's fundamental guidelines."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
NVMI
- NASDAQ - ELECTRONICS - Semiconductor Equipment & Mate
Nova Ltd
|
$224.05 |
+5.44
2.49%
|
$226.37
|
$247.21
|
-9.37% |
166,116 76.55%
|
217,000
|
Most Recent Note for NVMI - 8/27/2024 1:43:09 PM
Consolidating near its 50 DMA line ($221) after finding prompt support near its 200 DMA line ($178) on a sharp pullback. Reported Jun '24 quarterly earnings +52% on +28% sales revenues versus the year-ago period, a noted improvement after 7 quarterly comparisons below the +25% minimum earnings guideline (C criteria). Last noted wiuth caution in the 7/17/24 mid-day report - <i>"Annual earnings history (A criteria) has been up and down. This Semiconductor Equipment firm headquartered in Israel went through a deep consolidation since noted with caution in the 12/31/21 mid-day report."</i>
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
PKOH
- NASDAQ - MANUFACTURING - Metal Fabrication
Park Ohio Holding Corp
|
$30.19 |
-0.05 -0.17%
|
$30.58
|
$31.95
|
-5.51% |
23,937 77.22%
|
31,000
|
Most Recent Note for PKOH - 8/27/2024 1:45:49 PM
Through the Jun '24 quarter its sales revenues and earnings growth has not been strong and steady. Rallied impressively to new highs after briefly undercutting its 200 DMA line since last noted with caution in the 6/17/24 mid-day report.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
RMD
- NYSE - HEALTH SERVICES - Medical Appliances & Equipment
Resmed Inc
|
$236.67 |
+10.81
4.79%
|
$241.00
|
$231.50
|
2.23% |
923,214 82.28%
|
1,122,000
|
Most Recent Note for RMD - 8/27/2024 1:47:30 PM
Reported earnings +30% on +9% sales revenues for the Jun '24 quarter versus the year-ago period, its 2nd strong comparison. Prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) growth has been steady.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
UG
- NASDAQ - DRUGS - Drug Manufacturers - Other
United Guardian Inc
|
$14.63 |
+1.04
7.65%
|
$14.93
|
$13.88
|
5.40% |
15,368 102.45%
|
15,000
|
Most Recent Note for UG - 8/27/2024 1:49:25 PM
Perched at its 52-week high today while adding to a noted spurt of volume-driven gains, however, resistance remains due to old overhead supply up to the $26 level. Reported earnings +110% on +28% sales revenues for the Jun '24 quarterversus the year-ago period, and 3 of the 4 latest quarterly comparisons were above the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) history has not been strong and steady.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
|
|
THESE ARE NOT BUY RECOMMENDATIONS!
Comments contained in the body of this report are technical
opinions only. The material herein has been obtained
from sources believed to be reliable and accurate, however,
its accuracy and completeness cannot be guaranteed.
We are not an investment advisor, hence it does
not endorse or recommend any securities or other investments.
Any recommendation contained in this report may not
be suitable for all investors and it is not to be deemed
an offer or solicitation on our part with respect to
the purchase or sale of any securities. All trademarks,
service marks and trade names appearing in this report
are the property of their respective owners, and are
likewise used for identification purposes only.
This report is a service available
only to active Paid Premium Members.
You may opt-out of receiving report notifications
at any time. Questions or comments may be submitted
by writing to FactBasedInvesting.com c/o Premium
Member Services 665 S.E. 10 Street, Suite 201
Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.
We appreciate any feedback
members may wish to send via the inquiry form
here.
|
|